NeuroOne Medical Technologies Corporation NMTC
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| Wilmot B. Harkey | USA | 0 | 1214094 | 0 | 0 | 1214094 | 5.1 % | 14/02/2024 |
| Nantahala Capital Management, LLC | MA | 0 | 1214094 | 0 | 0 | 1214094 | 5.1 % | 14/02/2024 |
| Daniel Mack | USA | 0 | 1214094 | 0 | 0 | 1214094 | 5.1 % | 14/02/2024 |
| Laurence W. Lytton | USA | 1304102 | 0 | 1304102 | 0 | 1304102 | 11 % | 11/01/2024 |
| Manchester Explorer, L.P. | United States of America | 492951 | 3545789 | 492951 | 4992951 | 4000000 | 11.2 % | 21/01/2021 |
| Jeremy Neilson | Delaware | 0 | 0 | 0 | 0 | 683850 | 6.8 % | 14/01/2019 |
| Assure Fund Management II, LLC | Delaware | 0 | 0 | 0 | 0 | 683850 | 6.8 % | 14/01/2019 |
| FundRx NeuroOne Fund, a series of FundRx Master Fund I, LLC | Delaware | 683850 | 0 | 683850 | 0 | 683850 | 6.8 % | 14/01/2019 |
| 2. | State of Minnesota | 859976 | 0 | 859976 | 0 | 859976 | 10.9 % | 21/12/2018 |
| Wade Fredrickson | United States | 2840731 | 0 | 2840731 | 10 | 2840731 | 36.1 % | 28/07/2017 |
| Mark Christianson | United States | 1423206 | 0 | 1423206 | 0 | 1423206 | 18.1 % | 26/07/2017 |
| David A. Rosa | United States | 793822 | 0 | 793822 | 10 | 793822 | 10.1 % | 26/07/2017 |
| Amer Samad | U.S. | 3515728 | 0 | 3515728 | 0 | 3515728 | 69.3 % | 13/07/2017 |
| Lifestyle Healthcare LLC | U.S. | 542622 | 0 | 542622 | 0 | 542622 | 10.7 % | 13/07/2017 |
| Chromium 24 LLC | U.S. | 790499 | 0 | 790499 | 0 | 790499 | 15.58 % | 13/07/2017 |